INT205869

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.24
First Reported 2007
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 4
Disease Relevance 0.23
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
nucleus 1
intermediate region 1
G4 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cytokine 16 5.00 Very Low Very Low Very Low
iatrogenic 4 5.00 Very Low Very Low Very Low
palliative 2 5.00 Very Low Very Low Very Low
Central nervous system 2 5.00 Very Low Very Low Very Low
transdermal 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
metalloproteinase 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Contagious Ecthyma 10 88.16 High High
Enzootic Bovine Leukosis 26 50.00 Quite Low
Pressure And Volume Under Development 2 48.08 Quite Low
Lymphocytosis 66 5.00 Very Low Very Low Very Low
Infection 52 5.00 Very Low Very Low Very Low
Cancer 44 5.00 Very Low Very Low Very Low
Disease 38 5.00 Very Low Very Low Very Low
Apoptosis 36 5.00 Very Low Very Low Very Low
Leukemia 30 5.00 Very Low Very Low Very Low
Death 20 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In contrast, G4, like p13II, is localized both in the nucleus and in mitochondria [169].
Localization (localized) of G4 in nucleus
1) Confidence 0.24 Published 2007 Journal Retrovirology Section Body Doc Link PMC1839114 Disease Relevance 0.15 Pain Relevance 0
The R3 and G4 open reading frames (orfs) belong to an intermediate region located between the envelope and the tax/rex genes.
Localization (located) of G4 in intermediate region
2) Confidence 0.22 Published 2007 Journal Retrovirology Section Body Doc Link PMC1839114 Disease Relevance 0.08 Pain Relevance 0
However, more content of PLGA (85:15) showed the slowest BSA release in G4 among the formulations studied and it might be due to the enhancement of hydrophobicity.
Localization (release) of G4
3) Confidence 0.12 Published 2008 Journal International Journal of Nanomedicine Section Body Doc Link PMC2636584 Disease Relevance 0 Pain Relevance 0
When the cumulative percentages of the protein release from the experimental formulations were plotted against time, it was found that about 84% protein was released in 50 days in case of the formulation G3, whereas, G4 had a release of about 42% in the same time period (Figure 7).
Localization (release) of G4
4) Confidence 0.11 Published 2008 Journal International Journal of Nanomedicine Section Body Doc Link PMC2636584 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox